GLP-1 Weight Loss Drugs May Raise Osteoporosis, Gout Risk
GLP-1 Weight Loss Drugs May Raise Osteoporosis, Gout Risk is drawing significant interest across the industry.
New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone density issues and gout among users, prompting doctors to urge monitoring, balanced nutrition, and medical supervision during treatment. , Health, Times Now
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- India chip to set up first display driver chip unit
- Rachel Reeves backtracks on student loans as she says system is 'broken' a month after defending it as 'fair' to LBC
- The First Trailer for 'Scary Movie 6' Is Here to Eat Horror's Lunch Again
- Rupee Slips 7 Paise To 90.96 Against Dollar In Early Trade On Rising Oil, Stronger Dollar & Weak Equities
Source: Original →